These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7308258

  • 1. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds.
    Brock N, Pohl J, Stekar J.
    Eur J Cancer (1965); 1981 Jun; 17(6):595-607. PubMed ID: 7308258
    [No Abstract] [Full Text] [Related]

  • 2. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds.
    Brock N, Pohl J, Stekar J.
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1155-63. PubMed ID: 7199463
    [No Abstract] [Full Text] [Related]

  • 3. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
    Brock N, Stekar J, Pohl J, Niemeyer U, Scheffler G.
    Arzneimittelforschung; 1979 Nov; 29(4):659-61. PubMed ID: 114192
    [Abstract] [Full Text] [Related]

  • 4. Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.
    Pohl J, Stekar J, Hilgard P.
    Arzneimittelforschung; 1989 Jun; 39(6):704-5. PubMed ID: 2505783
    [Abstract] [Full Text] [Related]

  • 5. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
    Brock N, Pohl J, Stekar J, Scheef W.
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1377-87. PubMed ID: 6819957
    [Abstract] [Full Text] [Related]

  • 6. Influence of buthionine sulfoximine on the lethality of ifosfamide and ifosfamide-induced urotoxicity in mice.
    Ishikawa M, Takayanagi Y, Sasaki K.
    Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):455-8. PubMed ID: 2727395
    [Abstract] [Full Text] [Related]

  • 7. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
    Brock N, Pohl J, Stekar J.
    J Cancer Res Clin Oncol; 1981 Mar; 100(3):311-20. PubMed ID: 6792207
    [Abstract] [Full Text] [Related]

  • 8. Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.
    Conklin DJ, Haberzettl P, Lesgards JF, Prough RA, Srivastava S, Bhatnagar A.
    J Pharmacol Exp Ther; 2009 Nov; 331(2):456-69. PubMed ID: 19696094
    [Abstract] [Full Text] [Related]

  • 9. Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention .
    Dobrek Ł, Thor PJ.
    Postepy Hig Med Dosw (Online); 2012 Sep 10; 66():592-602. PubMed ID: 23001201
    [Abstract] [Full Text] [Related]

  • 10. Modification of cyclophosphamide-induced urotoxicity by buthionine sulfoximine and disulfiram in mice.
    Ishikawa M, Takayanagi Y, Sasaki K.
    Res Commun Chem Pathol Pharmacol; 1989 Aug 10; 65(2):265-8. PubMed ID: 2587846
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy.
    Gray KJ, Engelmann UH, Johnson EH, Fishman IJ.
    J Urol; 1986 Aug 10; 136(2):497-500. PubMed ID: 3090278
    [Abstract] [Full Text] [Related]

  • 12. The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.
    Brock N.
    Recent Results Cancer Res; 1980 Aug 10; 74():270-8. PubMed ID: 6777836
    [Abstract] [Full Text] [Related]

  • 13. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A, Korkmaz A, Oter S, Coskun O.
    Arch Toxicol; 2005 Aug 10; 79(8):461-5. PubMed ID: 15800758
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of berberine on cyclophosphamide-induced haemorrhagic cystitis in rats.
    Xu X, Malavé A.
    Pharmacol Toxicol; 2001 May 10; 88(5):232-7. PubMed ID: 11393582
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of S-allylcysteine against cyclophosphamide-induced bladder hemorrhagic cystitis in mice.
    Bhatia K, Ahmad F, Rashid H, Raisuddin S.
    Food Chem Toxicol; 2008 Nov 10; 46(11):3368-74. PubMed ID: 18786597
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of ifosfamide-induced urotoxicity by disulfiram in mice.
    Ishikawa M, Takayanagi Y, Sasaki K.
    Jpn J Pharmacol; 1989 Jan 10; 49(1):147-50. PubMed ID: 2724678
    [Abstract] [Full Text] [Related]

  • 17. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    Brock N, Pohl J.
    IARC Sci Publ; 1986 Jan 10; (78):269-79. PubMed ID: 3108156
    [Abstract] [Full Text] [Related]

  • 18. Urinary kidney injury molecule-1 (KIM-1) excretion in rats with experimental cystitis induced by oxazaphosphorines.
    Dobrek Ł, Skowron B, Baranowska A, Malska-Woźniak A, Thor P.
    Przegl Lek; 2016 Jan 10; 73(11):805-12. PubMed ID: 29693342
    [Abstract] [Full Text] [Related]

  • 19. [Prophylactic alkalization of the urine during cytostatic tumor treatment with the oxazaphosphorine derivatives, cyclophosphamide and ifosfamide].
    Brühl P, Hoefer-Janker H, Scheef W, Vahlensieck W.
    Onkologie; 1979 Jun 10; 2(3):120-4. PubMed ID: 42866
    [Abstract] [Full Text] [Related]

  • 20. The influence of oxazaphosphorines alkylating agents on autonomic nervous system activity in rat experimental cystitis model.
    Dobrek Ł, Baranowska A, Thor PJ.
    Acta Pol Pharm; 2013 Jun 10; 70(6):1097-105. PubMed ID: 24383333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.